Cipla Acquires Avenue, Primes Play In Pain Amid US Opioid Crisis

 
• By Anju Ghangurde

Cipla has struck a 'de-risked' deal to acquire the specialty firm Avenue Therapeutics, Inc, for up to $215m as it readies a niche play in the US pain management segment amid the opioid crisis.

USA
CIPLA HOPES TO CARVE A NICHE IN THE PAIN MANAGEMENT SPACE VIA AVENUE • Source: Shutterstock

More from India

More from Focus On Asia